The pharmaceutical industry in India has witnessed a tremendous growth from ₹2,585 billion in FY2019 to an estimated ₹4,142 billion in FY2024, recording a solid CAGR of 9.9%, a clear indicator of sustained growth momentum. To reap the growth benefits, VijayPD Ceutical Limited is all set with its upcoming IPO.
Smart Horizons Capital Advisors Limited is managing the VijayPD Ceutical IPO. The registrar for the same is Kfin Technologies Ltd. Do check out the allotment status.
For an in-depth review of this IPO, check out the VijayPD Ceutical Limited DRHP and Final Prospectus.
Note: Half of the VijayPD Ceuticals IPO shares will be unlocked 30 days after allotment, while the rest will be free from lock-in restrictions after 90 days.
Check out the company profile for VijayPD Ceuticals Ltd. below:
This portion covers all that you must know about the VijayPD Ceuticals IPO.
Check out the latest list of the best broker websites in India.
Let’s observe the major strengths and risks of the VijayPD Ceutical IPO.
Strengths
Focus on enhancing client relations: VijayPD leverages its strategic location in Mumbai and promotes long-term client relationships as a source to strengthen its market position. A majority of its customers are repeat customers.
Strong product portfolio: VijayPD has a diverse product portfolio ranging from generics, branded drugs, wellness, etc.
Experienced team: Promoters Narendra Nagindas Shah, Samit Madhukar Shah, Bhavin Dhirendra Shah, and Rahul Jitendra Shah bring with them a significant 6 decades of experience.
Well-managed supply chain: VijayPD ensures an efficient supply chain that provides them with timely delivery, cost-efficiency, and stronger customer satisfaction.
Risks
Expansion of API: The company plans to expand its Active Pharmaceutical Ingredients (API) manufacturing. While this presents a strong growth opportunity, it also exposes the company to financial, operational, and market risks.
Quality Control: Occasionally, products may be defective, expired, or damaged, which could negatively affect the company’s reputation.
Geographical concentration: A good amount of sales comes from Maharashtra. This exposes the company to geographical risk.
Industrial demand slowdown: VijayPD sales could largely be impacted by any slowdown in the industrial pharmaceutical demand.
VijayPD Ceuticals IPO is coming on September 29. Strong market position and an experienced management team are the company’s core strengths. Do not forget to check its GMP here.
Also, check out the live subscription details. Apply today.
1. What is the VijayPD Ceuticals IPO review?
VijayPD Ceuticals Ltd. is a pharmaceutical and consumer goods distributor company. Its core strengths include a strong market position and an experienced management team. However, their risks of geographical concentration and product quality are factors to consider. Check out the market sentiment with the latest GMP updates.
2. What is the VijayPD Ceuticals IPO date?
The VijayPD Ceuticals IPO opens on September 29, 2025, and the closing date is October 1, 2025. Tentative allotment date is October 3, 2025. You can check the Live subscription details now as well.
3. What is the VijayPD Ceuticals IPO price?
The VijayPD Ceuticals IPO price is ₹35. Its face value is ₹10 per share. Lot size is 4,000 shares. Check the allotment status here.
4. Should I use a demat account for the VijayPD Ceuticals IPO?
A demat account is mandatory to apply for any IPO, including the VijayPD Ceuticals IPO. Click here to get the latest list of the top demat account providers.
